BMJ 1995;311:1228 (4 November)

Letters

Controversy over new data on oral contraceptives

Risk of delay was small

EDITOR,--The rapidity with which the Committee on Safety of Medicines released its advice about the risk of thromboembolism associated with oral contraceptives has caused much anger, concern, and confusion.1 Critics of the committee maintain that (a) systems exist for the rapid dissemination of information to medical practitioners, (b) these systems could have disseminated information to medical practitioners within 12-48 hours, and (c) the short delay resulting ng from the use of thesesystems would have resulted in less confusion, concern, and anger. The committee seems, however, to have thought that the dangers were so great that no delay was acceptable.

How many women would have been harmed if Professor Michael Rawlins, the chairman of the committee, had delayed his announcement by 48 hours? Professor Rawlins's letter states that the maximum thromboembolic risk from oral contraceptives that do not contain desogestrol and gestodene is 10 cases per . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Controversy rages over new contraceptive data
Douglas Carnall
BMJ 1995 311: 1117-1118. [Extract] [Full Text]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ